ARCHIVES

Letrozole cuts risk of recurrent breast cancer in post-menopausal women.

This article is from The Cancer Letter archive.

Vol. 29 No. 38 | October 17, 2003

Download PDF Visit The Full Archive

Related Articles

Patient Care Emerges as Major Concern Following Sequestration Cuts to Medicare

April 5, 2013

Thomas Tomasi Named New Director Of Roswell Park

June 27, 1986

Phase III Trial Would Give Clearer Picture of C225 Role

March 8, 2002

Breast Cancer Risk Increases With Repeated CT Imaging

December 28, 2012

NIEHS Director Olden Outlines Strategy For Carcinogenicity Testing

September 11, 1992

Key Cancer Legislation Remains Unfinished as Congress Departs for Election.

October 6, 2006